BIOCERES CROP SOLUTIONS CORP (BIOX) Forecast, Price Target & Analyst Ratings

NASDAQ:BIOX • KYG1117K1141

Current stock price

0.5403 USD
+0.07 (+13.75%)
At close:
0.55 USD
+0.01 (+1.8%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOCERES CROP SOLUTIONS CORP (BIOX).

Forecast Snapshot

Consensus Price Target

Price Target
$2.04
+ 277.57% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q3 / 2026
EPS Estimate
-$0.05
Revenue Estimate
55.59M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$2.04
Upside
+ 277.57%
From current price of $0.54 to mean target of $2.04, Based on 6 analyst forecasts
Low
$2.02
Median
$2.04
High
$2.10

Price Target Revisions

1 Month
0.00%
3 Months
-51.02%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for BIOX. The average price target is 2.04 USD. This implies a price increase of 277.57% is expected in the next year compared to the current price of 0.5403.
The average price target has been revised downward by 51.02% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

BIOX Current Analyst RatingBIOX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

BIOX Historical Analyst RatingsBIOX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
BIOX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about BIOX.
In the previous month the buy percentage consensus was at a similar level.
BIOX was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-01-02Canaccord GenuityMaintains Hold -> Hold
2025-11-14Canaccord GenuityMaintains Hold -> Hold
2025-09-10Lake StreetMaintains Buy -> Buy
2025-09-10Canaccord GenuityDowngrade Buy -> Hold
2025-07-15OppenheimerMaintains Outperform -> Outperform
2025-04-22OppenheimerMaintains Outperform -> Outperform
2025-02-13Canaccord GenuityMaintains Buy -> Buy
2025-02-07Lake StreetMaintains Buy -> Buy
2025-02-07Canaccord GenuityMaintains Buy -> Buy
2025-01-28OppenheimerMaintains Outperform -> Outperform
2024-11-13Canaccord GenuityMaintains Buy -> Buy
2024-10-21OppenheimerMaintains Outperform -> Outperform
2024-10-17Canaccord GenuityMaintains Buy -> Buy
2024-09-11Roth MKMMaintains Buy -> Buy
2024-09-11Lake StreetMaintains Buy -> Buy
2024-09-11OppenheimerMaintains Outperform -> Outperform
2024-09-11Canaccord GenuityMaintains Buy -> Buy
2024-07-02Roth MKMReiterate Buy
2024-02-09Roth MKMMaintains Buy -> Buy
2023-11-01Roth MKMMaintains Buy -> Buy
2023-09-12Roth MKMReiterate Buy -> Buy
2023-09-12Lake StreetMaintains Buy -> Buy
2023-08-16Roth MKMReiterate Buy -> Buy
2023-04-06OppenheimerInitiate Outperform
2022-09-30Canaccord GenuityInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q3 / 2026
EPS Estimate
-$0.05
Revenue Estimate
55.59M
Revenue Q2Q
-8.27%
EPS Q2Q
-155.00%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-9.57%
EPS (1 Month)
0.00%
EPS (3 Months)
59.46%

Next Earnings Summary

The next earnings revenue estimate has been revised downward by 9.57% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
BIOX revenue by date.BIOX revenue by date.
415.095M
26.40%		464.829M
11.98%		333.344M
-28.29%		313.24M
-6.03%		431.72M
37.82%		521.22M
20.73%		590.78M
13.35%		665.35M
12.62%		738.99M
11.07%		773.16M
4.62%
EBITDA
YoY % growth
BIOX ebitda by date.BIOX ebitda by date.
71.765M
72.55%		65.53M
-8.69%		20.849M
-68.18%		47.43M
127.49%		76.704M
61.72%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
BIOX ebit by date.BIOX ebit by date.
52.375M
61.65%		44.234M
-15.54%		-1.333M
-103.01%		22.338M
1,775.39%		53.652M
140.18%		76.704M
42.97%		101.69M
32.57%		118.73M
16.76%		128.32M
8.08%		134.44M
4.77%
Operating Margin
BIOX operating margin by date.BIOX operating margin by date.
12.62%9.52%-0.40%7.13%12.43%14.72%17.21%17.84%17.36%17.39%
EPS
YoY % growth
BIOX eps by date.BIOX eps by date.
0.25
275.89%		0.06
-76.21%		-0.80
-1,457.63%		-0.16
79.63%		0.23
243.75%		0.57
143.48%		0.84
46.43%		1.01
20.73%		1.10
9.09%		1.15
4.63%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.05
-155.00%		-0.06
91.26%
Revenue
Q2Q % growth		55.59M
-8.27%		81.804M
9.51%
EBITDA
Q2Q % growth		4.386M
-76.13%		4.182M
-56.50%
EBIT
Q2Q % growth		2.346M
112.48%		-2.856M
77.27%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

BIOX Yearly Revenue VS EstimatesBIOX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
BIOX Yearly EPS VS EstimatesBIOX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 1

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
39.47%
EPS Next 5 Year
26.67%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
11.13%
Revenue Next 5 Year
11.87%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

BIOCERES CROP SOLUTIONS CORP / BIOX Forecast FAQ

What is the average price target for BIOCERES CROP SOLUTIONS CORP (BIOX) stock?

6 analysts have analysed BIOX and the average price target is 2.04 USD. This implies a price increase of 277.57% is expected in the next year compared to the current price of 0.5403.

Can you provide the consensus estimates for BIOCERES CROP SOLUTIONS CORP next earnings?

The consensus EPS estimate for the next earnings of BIOCERES CROP SOLUTIONS CORP (BIOX) is -0.05 USD and the consensus revenue estimate is 55.59M USD.

What is the expected long term growth rate for BIOCERES CROP SOLUTIONS CORP (BIOX)?

The expected long term growth rate for BIOCERES CROP SOLUTIONS CORP (BIOX) is 11.13%.